COVID-19 lung clot study reveals hidden risks
NCT ID NCT04465656
First seen Jan 22, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study followed 88 adults diagnosed with pulmonary embolism (blood clots in the lungs) during April 2020, the peak of the COVID-19 pandemic in France. Researchers compared complications like chronic lung disease, repeat clots, high blood pressure in the lungs, and death over 6 to 12 months between patients who had COVID-19 and those who did not. The goal was to understand how COVID-19 affects recovery from pulmonary embolism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Saint Joseph Marseille
Marseille, France
Conditions
Explore the condition pages connected to this study.